Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,092 | 236 | 99.8% |
| Education | $6.26 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $784.62 | 55 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $503.44 | 27 | $0 (2024) |
| Amgen Inc. | $463.24 | 31 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $178.49 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $177.68 | 13 | $0 (2022) |
| ABBVIE INC. | $157.78 | 12 | $0 (2024) |
| Amarin Pharma Inc. | $145.19 | 10 | $0 (2019) |
| Lilly USA, LLC | $144.47 | 10 | $0 (2024) |
| Elekta, Inc. | $139.92 | 1 | $0 (2017) |
| Novo Nordisk Inc | $134.07 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.53 | 37 | AstraZeneca Pharmaceuticals LP ($203.90) |
| 2023 | $634.37 | 36 | Corcept Therapeutics ($107.92) |
| 2022 | $419.90 | 23 | Bayer HealthCare Pharmaceuticals Inc. ($139.02) |
| 2021 | $475.60 | 27 | Boehringer Ingelheim Pharmaceuticals, Inc. ($125.00) |
| 2020 | $376.38 | 24 | AstraZeneca Pharmaceuticals LP ($125.34) |
| 2019 | $380.79 | 28 | AstraZeneca Pharmaceuticals LP ($107.31) |
| 2018 | $444.50 | 33 | AstraZeneca Pharmaceuticals LP ($112.69) |
| 2017 | $706.51 | 29 | Amgen Inc. ($140.88) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Respiratory | ||||||
| 10/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 09/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Biological | ||||||
| 06/08/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $130.08 | General |
| Category: BIOLOGIC | ||||||
| 06/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes Care | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,091 | 3,660 | $219,033 | $131,136 |
| 2022 | 12 | 1,109 | 3,895 | $219,868 | $131,781 |
| 2021 | 14 | 1,175 | 3,696 | $221,294 | $133,630 |
| 2020 | 14 | 1,287 | 3,885 | $219,943 | $114,904 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 496 | $99,200 | $53,691 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 361 | $54,150 | $26,912 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 168 | 168 | $27,461 | $23,890 | 87.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,924 | $12,000 | $8,893 | 74.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 180 | 180 | $5,400 | $3,732 | 69.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 158 | 158 | $4,740 | $3,290 | 69.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $2,880 | $2,586 | 89.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 37 | $3,487 | $2,495 | 71.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,504 | $2,156 | 86.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 215 | $4,300 | $1,806 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,800 | $1,223 | 67.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 32 | 37 | $1,110 | $462.96 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 501 | $100,200 | $54,340 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 425 | $63,750 | $33,175 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 146 | 146 | $21,198 | $21,124 | 99.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 21 | 2,100 | $7,600 | $5,118 | 67.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 165 | 165 | $4,950 | $3,587 | 72.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 46 | $3,300 | $3,150 | 95.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 142 | 142 | $4,260 | $3,026 | 71.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $3,195 | $2,829 | 88.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 22 | 36 | $3,655 | $2,565 | 70.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 48 | $1,780 | $1,523 | 85.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 51 | 56 | $1,680 | $707.64 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 99 | 215 | $4,300 | $636.87 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 438 | $87,550 | $48,102 | 54.9% |
About Dr. Anna Lee, MD
Dr. Anna Lee, MD is a Internal Medicine healthcare provider based in East Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780625038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Lee, MD has received a total of $4,099 in payments from pharmaceutical and medical device companies, with $660.53 received in 2024. These payments were reported across 237 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,092).
As a Medicare-enrolled provider, Lee has provided services to 4,662 Medicare beneficiaries, totaling 15,136 services with total Medicare billing of $511,451. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location East Brunswick, NJ
- Active Since 06/09/2006
- Last Updated 09/19/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780625038
Products in Payments
- FARXIGA (Drug) $626.67
- JARDIANCE (Drug) $326.14
- Prolia (Biological) $234.30
- Kerendia (Drug) $178.49
- JANUVIA (Drug) $151.56
- Vascepa (Drug) $145.19
- Esteya (Device) $139.92
- RUCONEST (Biological) $130.08
- OFEV (Drug) $125.00
- EVENITY (Biological) $111.73
- Korlym (Drug) $107.92
- NEXLETOL (Drug) $93.63
- BREZTRI (Drug) $83.54
- Cologuard Collection Kit (Device) $80.85
- CREON (Drug) $79.98
- Ozempic (Drug) $78.58
- TRELEGY ELLIPTA (Drug) $77.88
- XARELTO (Drug) $65.18
- LINZESS (Drug) $64.88
- HARMONY (Device) $59.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Brunswick
David Schaer, Md, MD
Internal Medicine — Payments: $92,124
Aamer Farooq, Md, MD
Internal Medicine — Payments: $19,081
Dr. Lev Simkhayev, M.d, M.D
Internal Medicine — Payments: $11,458
Dr. Ahab Gabriel
Internal Medicine — Payments: $8,656
Sarath Babu, Md, MD
Internal Medicine — Payments: $8,399
Scott Yager, M.d, M.D
Internal Medicine — Payments: $8,091